Skip to main content

AGENUS INC

For the period ended Dec 31, 2024. Filed Mar 17, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 17, 2025

AGEN$7.150.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

(Amounts in thousands, except share and per share amounts)

December 31, 2024December 31, 2023
ASSETS
Cash and cash equivalents$40,437$76,110
Accounts receivable40725,836
Prepaid expenses2,3158,098
Other current assets2,4152,372
Total current assets45,574112,416
Property, plant and equipment, net of accumulated amortization and depreciation of $72,553 and $61,943 at December 31, 2024 and 2023, respectively120,087133,421
Operating lease right-of-use assets27,30829,606
Goodwill24,09224,723
Acquired intangible assets, net of accumulated amortization of $16,986 and $17,688 at December 31, 2024 and 2023, respectively3,3764,411
Other long-term assets5,8349,336
Total assets$226,271$313,913
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current portion, long-term debt$2,698$146
Current portion, liability related to sale of future royalties and milestones111,978132,502
Current portion, deferred revenue3118
Current portion, operating lease liabilities2,4462,587
Accounts payable61,47061,446
Accrued liabilities34,96145,283
Other current liabilities7,81713,915
Total current liabilities221,401255,897
Long-term debt, net of current portion30,47312,768
Liability related to sale of future royalties and milestones, net of current portion224,389124,556
Deferred revenue, net of current portion1,1431,143
Operating lease liabilities, net of current portion54,55162,511
Other long-term liabilities7385,420
Commitments and contingencies (Note 19)
STOCKHOLDERS’ DEFICIT
Preferred stock, par value $0.01 per share; 5,000,000 shares authorized:
Series A-1 convertible preferred stock; 31,620 shares designated, issued, and outstanding at December 31, 2024 and 2023; liquidation value of $34,101 and $33,886 at December 31, 2024, and 2023, respectively00
Common stock, par value $0.01 per share; 800,000,000 shares authorized at December 31, 2024 and 2023; 23,634,670 shares and 19,718,662 shares issued at December 31, 2024 and 2023, respectively236197
Additional paid-in capital1,857,6621,796,095
Accumulated other comprehensive loss(1,398)(955)
Accumulated deficit(2,182,880)(1,955,668)
Total stockholders’ deficit attributable to Agenus Inc.(326,380)(160,331)
Non-controlling interest19,95611,949
Total stockholders’ deficit(306,424)(148,382)
Total liabilities, convertible preferred stock and stockholders’ deficit$226,271$313,913
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.